Dr. Pranav Penninti, DO

Dr. Penninti practices at Central Ohio Endoscopy Center - Columbus (Olentangy River Rd) in Columbus, Ohio.

Dr. Penninti's NPI, 1699200436, was assigned on May 1, 2017. Dr. Penninti graduated from Texas College of Osteopathic Medicine in 2017. Dr. Penninti holds Ohio license 34.017196.

Dr. Penninti's primary practice is Central Ohio Endoscopy Center - Columbus (Olentangy River Rd), at 3400 Olentangy River Rd, Columbus, OH 43202. The practice phone is (614) 754-5500.

Dr. Penninti's primary practice is Central Ohio Endoscopy Center - Columbus (Olentangy River Rd) in Columbus, Ohio. Dr. Penninti is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Penninti to 4 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account. Dr. Penninti's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Penninti practices, 9 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Penninti's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Penninti is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Penninti is licensed in Ohio.

CMS data shows 98 Medicare services from Dr. Penninti across 4 procedure codes in 2024, for 100 Medicare patients. Medicare paid $4,813 for them. Every service was in an office.

CMS counts 100 Medicare patients who saw Dr. Penninti in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Penninti's median patient age at 61, with 52% women.

In 2024, Dr. Penninti wrote 74 Medicare Part D claims for 50 patients. 92% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $401 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Penninti for performance year 2024, reported as part of a group. Dr. Penninti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Penninti as offering telehealth. CMS counts 50 procedures of colonoscopy by Dr. Penninti, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Penninti, published from 2013 to 2024. 2023 was the busiest year, with 2. Dr. Penninti has published most often in Clin Liver Dis (Hoboken). Dr. Penninti's most frequent co-authors are Stela Celaj, MD, PhD, Aylin Rachel Rodan, MD and Ashwani Kumar Singal, MD, MS.

CMS Open Payments shows 11 general payments to Dr. Penninti from 7 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $122.

Dr. Penninti graduated from Texas College of Osteopathic Medicine in 2017.

Dr. Penninti is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.